As Americans continue to come to grips with a deadly prescription drug epidemic, the Big Pharmaceutical industry continues to actively pursue the addictions of their customers.
Painkillers in the opioid class rely on the same receptor-altering chemicals as horrific street drugs such as heroin, with precisely the same proclivity for creating longtime abusers due to their sky high addiction rates. Drugs like oxycontin, vicodin, hydrocodone, and others have long been pushed on the populace by greedy and enormous drug manufacturers through incentive programs and market monopolies. As these prescriptions run dry, the addictions they cause linger, creating fiends out of ordinary Americans. In an effort to slake their thirst, many will turn to illegal narcotics that provide the same high with none of the manufacturing regulation to keep them at least somewhat safe.
Trending: The Solar Observatory Mystery
In that arena, a new scourge has emerged in the form of a drug called “fentanyl”, which is far more potent than heroin and other, legal opioids, and has caused a spike in overdose related deaths in America.
Now, as evidence has begun suggesting that medical marijuana decreases the likelihood of opioid addiction in legalized locales, the makers of fentanyl are relying on their Washington establishment pals to keep them in business, and to keep Americans addicted to their dangerous drugs.
Worse yet…they’ve been doing this since last September.
“An embattled pharmaceutical company that sells the powerful painkiller fentanyl has donated $500,000 toward defeating a ballot initiative that would make recreational use of marijuana legal under Arizona law.
“It’s hard to imagine a more sinister donor than Insys Therapeutics Inc. in the eyes of pot legalization proponents, who long have claimed drug companies want to keep cannabis illegal to corner the market for drugs, some addictive and dangerous, that relieve pain and other symptoms.
“Insys currently markets just one product, according to an August filing with the Securities and Exchange Commission: a sublingual fentanyl spray it calls Subsys.
“Two former company employees pleaded not guilty last month to federal charges related to an alleged kickback scheme to get doctors to prescribe Subsys.
“Illinois Attorney General Lisa Madigan filed a lawsuit late last month against the company alleging Insys hawked the drug to doctors for off-label prescribing, saying the company’s ‘desire for increased profits led it to disregard patients’ health and push addictive opioids for non-FDA approved purposes.'”
The above quoted piece is from over a year ago, yet no progress has been made in the fight against fentanyl.
Even worse are new reports that Obamacare-mandated health insurance providers are in on the scheme to get more Americans addicted to the perilous drugs.
“Few decisions in healthcare are made without insurers’ involvement. And, according to a ProPublica/New York Times investigation, insurers are discouraging doctors from writing prescriptions for cheaper, less-addictive painkillers, and instead encouraging the prescription of opiates.
“The news organizations took a look at nearly 36 million prescription drug plans offered under Medicare, the single-payer health plan available to Americans 65 and older and to younger Americans with disabilities. More than 55 million Americans are covered by Medicare.”
Without a drastic change to the way Americans view their healthcare, and the addiction that is inherent with the use of opioids, there is little hope that the Big Pharmaceutical industry will do the right thing on their own.
For them, this is all about creating and maintaining an addicted, active user base who will continue to increase the demand for their products. Fentanyl, like vicodin before it, will continue to enslave and kill Americans until common sense can interject itself into the conservation on Capitol Hill.